Results 1 to 10 of about 3,163 (211)

Synthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts [PDF]

open access: yesPhysiological Reports
Females exhibit distinct responses to exercise‐induced muscle damage, possibly due to circulating hormone profiles. Despite the widespread use of oral contraceptives (OC) among females, the muscle damage and repair response during synthetic hormone use ...
Mai Wageh, Michael Kamal, Gianni Parise
doaj   +3 more sources

Patient-Reported Tolerability, Treatment Initiation, and Discontinuation of Postoperative Progestin Therapy After Cesarean Scar Repair in Women Planning Pregnancy [PDF]

open access: yesMedicina
Background and Objectives: Cesarean scar disorder (CSDi) may require surgical repair in women with a large niche and thin residual myometrium. At our center, temporary postoperative progestin therapy is recommended to suppress cyclic endometrial ...
Tilman Born   +6 more
doaj   +2 more sources

Efficacy and safety of desogestrel/ethinylestradiol 150/20 flexible extended regimen (FREEDOM 150/20) in dysmenorrhea: phase 3 study in Japan [PDF]

open access: yesF&S Reports
Objective: To evaluate the efficacy and long-term safety of a user-driven flexible extended regimen of desogestrel 150 μg/ethinylestradiol 20 μg (DSG/EE 150/20) for the treatment of primary or secondary dysmenorrhea in women from Japan.
Kaori Koga, M.D., Ph.D.   +5 more
doaj   +2 more sources

Progestogen use and the risk of intracranial meningioma: a systematic review and meta-analysisResearch in context [PDF]

open access: yesEClinicalMedicine
Summary: Background: Meningiomas are the most common primary brain tumours in adults. Concerns have emerged about a possible link between progestogen use and intracranial meningioma; we assessed this association.
Benoit Hudelist   +12 more
doaj   +2 more sources

Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS) [PDF]

open access: yesScientific Reports
Progestogens commonly used in the clinic include levonorgestrel, etonogestrel, medroxyprogesterone, hydroxyprogesterone, progesterone, desogestrel, and megestrol.
Hui Gao, Xiaohan Zhai, Yan Hu, Hang Wu
doaj   +2 more sources

Control of side effects in strategy for increasing adherence to combined oral contraceptives. The role for a three-phase desogestrel-containing drug

open access: yesАкушерство, гинекология и репродукция, 2022
Introduction. The frequency of side effects when taking combined oral contraceptives (COCs) is still high, which is the reason for refusal to take COCs by women worldwide with a frequency of 30 to 81 %.
G. B. Dikke
doaj   +1 more source

Progesterone contraceptives: a place in practical gynecology (to practitioner aid) [PDF]

open access: yesГинекология, 2018
Progesterone-containing contraceptives do not have a significant impact on metabolic processes and can be prescribed to patients with systemic (diabetes mellitus, obesity) and other diseases. Desogestrel is a part of oral preparations in a dose of 75 mcg.
Y E Dobrokhotova   +2 more
doaj   +1 more source

Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT

open access: yesHealth Technology Assessment, 2021
Introduction: Unless women start effective contraception after using emergency contraception, they remain at risk of unintended pregnancy. Most women in the UK obtain emergency contraception from community pharmacies that are unable to provide ongoing ...
Sharon T Cameron   +16 more
doaj   +1 more source

Use of desogestrel-containing three-phase peroral contraceptives. Resolution of the meeting of the expert council

open access: yesГинекология, 2021
The meeting of the expert council on the rational use of desogestrel-containing three-phase oral contraceptives was held on August 20, 2020.
Editorial Board
doaj   +1 more source

Avaliação da tolerabilidade e do controle de ciclo de dois contraceptivos orais de baixa dose: estudo comparativo aberto Assessment of the tolerability and cycle control of two low-dose oral contraceptives: an open-label study

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 1998
Realizou-se um estudo aberto comparativo em nove centros brasileiros para avaliar a tolerabilidade e o controle de ciclo obtido com o uso de dois contraceptivos orais de baixa dose contendo 20 mg etinilestradiol/75 mg gestodeno e 20 mg etinilestradiol ...
Edmund C. Baracat   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy